CombinedX AB (publ) (FRA:K13)

Market Cap	63.34M
Revenue (ttm)	83.19M
Net Income (ttm)	4.14M
Shares Out	n/a
EPS (ttm)	0.22
PE Ratio	15.31
Forward PE	n/a
Dividend	0.13 (3.95%)
Ex-Dividend Date	May 8, 2025

Volume	n/a
Average Volume	n/a
Open	3.260
Previous Close	3.260
Day's Range	3.250 - 3.260
52-Week Range	2.540 - 4.010
Beta	n/a
RSI	33.74
Earnings Date	Jul 18, 2025

About Intra-Cellular Therapies

CombinedX AB (publ) provides technology solutions to companies and organizations. It also offers services in the areas of digital business development and transformation, service design and customer experience, business systems and processes, data analysis and decision support, automation and robotization, application development and lifecycle management, the digital workplace and identity management, managed infrastructure services and security, internet of things, customer relationship management, and change- and process management. CombinedX...

• Industry: Computer Programming, Data Processing, And Other Computer Related Services
• Founded: 2013
• Employees: 585
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: K13

Financial Performance

In 2024, CombinedX AB's revenue was 930.80 million, an increase of 21.48% compared to the previous year's 766.20 million. Earnings were 50.60 million, a decrease of -28.63%.